Stockreport

MacroGenics down 3% on uncertainty of margetuximab survival benefit [Seeking Alpha]

MacroGenics, Inc.  (MGNX) 
Last macrogenics, inc. earnings: 11/6 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.macrogenics.com
PDF MacroGenics ( MGNX -2.9% results SOPHIA Overall survival (OS) favored margetuximab, but the separation was not statistically significant. Specifically, median OS was 21. [Read more]